GlassScriptPhysician profile
Jeffrey A Perri
NPI 1003872813
$11,232.64
in general payments reported to CMS, 2019-2025
18 companies · $934 in 2025
The $934 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $198 · 2020: $112 · 2021: $240 · 2022: $5,083 · 2023: $278 · 2024: $4,388 · 2025: $934.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,848 · Food and Beverage: $1,661 · Education: $1,000 · Gift: $90.55.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,848.03 |
| Food and Beverage | $1,661.24 |
| Education | $1,000.00 |
| Gift | $90.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,434.59 | 2022-2024 | Da Vinci Surgical System |
| Medtronic, INC. | $1,494.73 | 2022-2024 | Absorbatack |
| Davol INC. | $1,305.97 | 2019-2025 | Phasix Mesh |
| Ethicon US, LLC | $179.63 | 2021-2023 | Ethicon, Echelon; Endopath, Dermabond |
| Csl Behring | $128.34 | 2024-2025 | Kcentra, Haegarda, Andembry |
| Pacira Pharmaceuticals Incorporated | $112.10 | 2019-2023 | Exparel, Zilretta, Iovera |
| Braintree Laboratories, INC. | $81.81 | 2024 | Suflave |
| Organogenesis INC. | $81.44 | 2023-2025 | Puraply Wound Matrix, Affinity, Puraply |
| Becton, Dickinson and Company | $77.87 | 2024 | Arista Ah Flexitip, Phasix Mesh, Bard 3dmax Mesh |
| Conmed Corporation | $70.58 | 2023-2025 | Airseal |
| Cumberland Pharmaceuticals, INC. | $67.45 | 2024-2025 | Caldolor |
| Lifenet Health | $60.76 | 2024 | Theragenesis Wound Matrix |
| Merck Sharp & Dohme LLC | $41.65 | 2022-2023 | Bridion |
| Acelrx Pharmaceuticals, INC. | $26.04 | 2019 | |
| Allergan, INC. | $23.10 | 2019-2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $18.37 | 2024 | Grafix Pl |
| Innocoll Pharmaceuticals Limited | $14.34 | 2021 | |
| Z-Medica, LLC | $13.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Perri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.